Brainstorm Cell Therapeutics Uk Ltd

General information

Name:

Brainstorm Cell Therapeutics Uk Limited

Office Address:

Suite 1, 7th Floor 50 Broadway SW1H 0BL London

Number: 08410584

Incorporation date: 2013-02-19

End of financial year: 28 February

Category: Private Limited Company

Status: Active

Description

Data updated on:

Brainstorm Cell Therapeutics Uk came into being in 2013 as a company enlisted under no 08410584, located at SW1H 0BL London at Suite 1, 7th Floor. This company has been in business for eleven years and its current state is active. The firm's principal business activity number is 21200, that means Manufacture of pharmaceutical preparations. The latest financial reports were submitted for the period up to 2022-02-28 and the latest annual confirmation statement was submitted on 2023-02-19.

Uri Y. is the following enterprise's solitary director, that was chosen to lead the company on 2015/06/30. For two years Liat S., had performed the duties for the business up to the moment of the resignation 9 years ago. Another limited company has been appointed as one of the secretaries of this company: Jordan Company Secretaries Limited.

Financial data based on annual reports

Company staff

Uri Y.

Role: Director

Appointed: 30 June 2015

Latest update: 24 January 2024

Role: Corporate Secretary

Appointed: 19 February 2013

Address: Templeback, 10 Temple Back, Bristol, BS1 6FL, United Kingdom

Latest update: 24 January 2024

People with significant control

The companies with significant control over this firm are: Brainstorm Cell Therapeutics Inc. owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Hackensack at Suite 320, 07601, New Jersey and was registered as a PSC under the reg no Bcli.

Brainstorm Cell Therapeutics Inc.
Address: Three University Plaza Drive Suite 320, Hackensack, New Jersey, 07601, United States
Legal authority Usa
Legal form Public Corporation
Country registered Usa (Other)
Place registered Nasdaq: Bcli
Registration number Bcli
Notified on 6 April 2016
Nature of control:
over 3/4 of shares
3/4 to full of voting rights
right to manage directors

Accounts Documents

Account next due date 30 November 2023
Account last made up date 28 February 2022
Confirmation statement next due date 04 March 2024
Confirmation statement last made up date 19 February 2023
Annual Accounts 19 November 2015
Start Date For Period Covered By Report 2014-03-01
End Date For Period Covered By Report 2015-02-28
Date Approval Accounts 19 November 2015
Annual Accounts
Start Date For Period Covered By Report 29 February 2020
End Date For Period Covered By Report 28 February 2021
Annual Accounts
Start Date For Period Covered By Report 01 March 2021
End Date For Period Covered By Report 28 February 2022
Annual Accounts
Start Date For Period Covered By Report 01 March 2022
End Date For Period Covered By Report 28 February 2023

Company filings

Filing category

Hide filing type
Accounts Address Annual return Confirmation statement Incorporation Officers
Free Download
Confirmation statement with no updates Mon, 19th Feb 2024 (CS01)
filed on: 23rd, February 2024
confirmation statement
Free Download Download filing (3 pages)

Search other companies

Services (by SIC Code)

  • 21200 : Manufacture of pharmaceutical preparations
  • 21100 : Manufacture of basic pharmaceutical products
  • 72110 : Research and experimental development on biotechnology
11
Company Age

Closest Companies - by postcode